Peptide therapy has moved from niche biohacking circles into mainstream medicine, and the regulatory landscape around it is actively evolving. In this panel discussion, Shaun Noorian (Founder & CEO, Empower Pharmacy), Dr. Rekha Kumar (Senior Medical Advisor, Found), and Dr. Alex Tatem (Corporate Director of Men's Health, U.S. Urology) join moderator Christina Farr (CEO, Second Opinion; GP, Scrub Capital) to unpack what responsible, evidence-based peptide therapy looks like today. Watch the full conversation below.